Loomis, Sayles & Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Buy |
+140,484
| New | +$17.7M | 0.02% | 261 |
|
|
2024
Q4 | – | Sell |
-150,337
| Closed | -$17.3M | – | 769 |
|
|
2024
Q3 | $17.3M | Sell |
150,337
-9,933
| -6% | -$1.14M | 0.02% | 281 |
|
|
2024
Q2 | $22.1M | Sell |
160,270
-94,663
| -37% | -$13M | 0.03% | 245 |
|
|
2024
Q1 | $35.2M | Sell |
254,933
-936
| -0.4% | -$129K | 0.05% | 174 |
|
|
2023
Q4 | $33.7M | Sell |
255,869
-1,057
| -0.4% | -$139K | 0.05% | 177 |
|
|
2023
Q3 | $28.9M | Buy |
256,926
+49,787
| +24% | +$5.6M | 0.05% | 193 |
|
|
2023
Q2 | $19.5M | Buy |
207,139
+44,136
| +27% | +$4.16M | 0.03% | 254 |
|
|
2023
Q1 | $16.5M | Buy |
+163,003
| New | +$16.5M | 0.03% | 261 |
|
|
2022
Q4 | – | Sell |
-1,910
| Closed | -$203K | – | 946 |
|
|
2022
Q3 | $203K | Sell |
1,910
-142
| -7% | -$15.1K | ﹤0.01% | 471 |
|
|
2022
Q2 | $200K | Buy |
2,052
+19
| +0.9% | +$1.85K | ﹤0.01% | 503 |
|
|
2022
Q1 | $191K | Buy |
+2,033
| New | +$191K | ﹤0.01% | 553 |
|
|
2021
Q4 | – | Sell |
-270,355
| Closed | -$25.9M | – | 859 |
|
|
2021
Q3 | $25.9M | Buy |
270,355
+7,531
| +3% | +$722K | 0.03% | 269 |
|
|
2021
Q2 | $25.6M | Buy |
262,824
+10,327
| +4% | +$1.01M | 0.03% | 268 |
|
|
2021
Q1 | $24.6M | Buy |
252,497
+377
| +0.1% | +$36.7K | 0.03% | 261 |
|
|
2020
Q4 | $24.2M | Buy |
252,120
+48,721
| +24% | +$4.67M | 0.03% | 237 |
|
|
2020
Q3 | $19.6M | Buy |
203,399
+17,892
| +10% | +$1.72M | 0.03% | 236 |
|
|
2020
Q2 | $22.6M | Buy |
185,507
+14,362
| +8% | +$1.75M | 0.04% | 200 |
|
|
2020
Q1 | $14.8M | Sell |
171,145
-2,772
| -2% | -$240K | 0.03% | 227 |
|
|
2019
Q4 | $18.7M | Sell |
173,917
-12,541
| -7% | -$1.35M | 0.03% | 227 |
|
|
2019
Q3 | $16.8M | Buy |
186,458
+68,786
| +58% | +$6.2M | 0.03% | 239 |
|
|
2019
Q2 | $9.94M | Sell |
117,672
-7,085
| -6% | -$598K | 0.02% | 344 |
|
|
2019
Q1 | $11M | Buy |
124,757
+22,744
| +22% | +$2M | 0.02% | 330 |
|
|
2018
Q4 | $7.28M | Buy |
102,013
+1,121
| +1% | +$80K | 0.02% | 370 |
|
|
2018
Q3 | $12.4M | Sell |
100,892
-8,047
| -7% | -$989K | 0.02% | 325 |
|
|
2018
Q2 | $10.7M | Sell |
108,939
-3,824
| -3% | -$376K | 0.02% | 402 |
|
|
2018
Q1 | $9.35M | Sell |
112,763
-2,016
| -2% | -$167K | 0.02% | 439 |
|
|
2017
Q4 | $8.91M | Buy |
114,779
+9,330
| +9% | +$724K | 0.02% | 452 |
|
|
2017
Q3 | $6.46M | Sell |
105,449
-2,735
| -3% | -$168K | 0.01% | 486 |
|
|
2017
Q2 | $4.98M | Buy |
108,184
+22,980
| +27% | +$1.06M | 0.01% | 512 |
|
|
2017
Q1 | $3.69M | Buy |
85,204
+14,396
| +20% | +$623K | 0.01% | 535 |
|
|
2016
Q4 | $2.74M | Sell |
70,808
-1,174
| -2% | -$45.4K | 0.01% | 569 |
|
|
2016
Q3 | $3.65M | Buy |
71,982
+71,819
| +44,061% | +$3.64M | 0.01% | 545 |
|
|
2016
Q2 | $7K | Buy |
163
+53
| +48% | +$2.28K | ﹤0.01% | 797 |
|
|
2016
Q1 | $4K | Sell |
110
-337,604
| -100% | -$12.3M | ﹤0.01% | 955 |
|
|
2015
Q4 | $19.1M | Buy |
337,714
+45,023
| +15% | +$2.55M | 0.05% | 302 |
|
|
2015
Q3 | $11.6M | Buy |
292,691
+3,891
| +1% | +$155K | 0.03% | 408 |
|
|
2015
Q2 | $13.8M | Buy |
288,800
+38,837
| +16% | +$1.85M | 0.04% | 421 |
|
|
2015
Q1 | $9.93M | Sell |
249,963
-225,877
| -47% | -$8.97M | 0.03% | 489 |
|
|
2014
Q4 | $10.6M | Sell |
475,840
-558,519
| -54% | -$12.5M | 0.03% | 493 |
|
|
2014
Q3 | $16.2M | Sell |
1,034,359
-23,874
| -2% | -$374K | 0.05% | 397 |
|
|
2014
Q2 | $15.7M | Buy |
1,058,233
+188,869
| +22% | +$2.8M | 0.04% | 426 |
|
|
2014
Q1 | $14M | Buy |
+869,364
| New | +$14M | 0.04% | 446 |
|
|
2013
Q3 | – | Sell |
-1,120,333
| Closed | -$15K | – | 754 |
|
|
2013
Q2 | $15K | Buy |
+1,120,333
| New | +$15K | 0.05% | 382 |
|